After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care
-
By
-
Anna Zucker
-
May 28, 2026
-
Objective:
To address the gap between increased access to GLP-1 medications through telehealth and the lack of sufficient clinical support for patients.
Key Findings:
- GLP-1 medications can lead to significant weight loss but may also result in loss of lean tissue without proper nutritional support.
- Telehealth patients have reported adverse effects such as fatigue and hair loss, attributed to inadequate calorie and nutrient intake.
- A hybrid model combining telehealth prescriptions with clinical support is recommended to improve patient care.
Interpretation:
Limitations:
- The study findings are based on a limited number of clinical trials and patient reports.
- There is a potential bias in self-reported experiences from telehealth patients.
Conclusion:
